Literature DB >> 23554037

Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children.

A Hammad1, Y Mosaad, S Elhanbly, H Youssef, A El Refaaey, F Elhusseini, A Bakr.   

Abstract

INTRODUCTION: More than 60% of children with systemic lupus erythematosus (SLE) develop lupus nephritis (LN). Neutrophil gelatinase-associated lipocalin (NGAL) is a protein secreted by leukocytes during inflammation and is overexpressed in the kidneys following ischemic and nephrotoxic damage. AIM: To study urinary and serum NGAL in children with SLE and investigate their possible role as markers of renal involvement. Methods Urinary and serum levels of NGAL were assessed in 33 children with active SLE (22 with and 11 without LN) and compared to 15 matched controls.
RESULTS: Children with SLE had elevated urinary NGAL as compared to controls (P<0.001). Levels of urinary NGAL were higher in patients with LN than those without LN (P<0.001). In patients with LN, serum levels of NGAL were not significantly different from controls (P=0.4) and urinary NGAL correlated with the renal score of the Systemic Lupus Erythematosus Disease Activity Index (r=0.5, P=0.02) but not with serum NGAL (P=0.5). Urinary NGAL was significantly predictive of class III and IV LN (P=0.005) with 91% sensitivity and 70% specificity to levels ≥ 10.07 ng/mg creatinine. Conclusions Urinary NGAL is a sensitive marker of proliferative nephritis in juvenile SLE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23554037     DOI: 10.1177/0961203313479419

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  6 in total

1.  Urinary clusterin-a novel urinary biomarker associated with pediatric lupus renal histopathologic features and renal survival.

Authors:  Chao-Yi Wu; Huang-Yu Yang; Hui-Ping Chien; Min-Hua Tseng; Jing-Long Huang
Journal:  Pediatr Nephrol       Date:  2018-03-06       Impact factor: 3.714

2.  Predicting decline of kidney function in lupus nephritis using urine biomarkers.

Authors:  K M Abulaban; H Song; X Zhang; P L Kimmel; J W Kusek; R G Nelson; H I Feldman; R S Vasan; J Ying; M Mauer; G L Nelsestuen; M Bennett; H I Brunner; B H Rovin
Journal:  Lupus       Date:  2016-02-11       Impact factor: 2.911

3.  A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis.

Authors:  Carolina Landolt-Marticorena; Stephenie D Prokopec; Stacey Morrison; Babak Noamani; Dennisse Bonilla; Heather Reich; James Scholey; Carmen Avila-Casado; Paul R Fortin; Paul C Boutros; Joan Wither
Journal:  Arthritis Res Ther       Date:  2016-10-04       Impact factor: 5.156

4.  Elevated Urinary Neutrophil Gelatinase-Associated Lipocalin Is a Biomarker for Lupus Nephritis: A Systematic Review and Meta-Analysis.

Authors:  Yueming Gao; Bin Wang; Jingyuan Cao; Songtao Feng; Bicheng Liu
Journal:  Biomed Res Int       Date:  2020-06-30       Impact factor: 3.411

Review 5.  The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases.

Authors:  Vanessa Abella; Morena Scotece; Javier Conde; Rodolfo Gómez; Ana Lois; Jesús Pino; Juan J Gómez-Reino; Francisca Lago; Ali Mobasheri; Oreste Gualillo
Journal:  Biomarkers       Date:  2015-12-15       Impact factor: 2.658

6.  Effects of Therapy on Urine Neutrophil Gelatinase-Associated Lipocalin in Nondiabetic Glomerular Diseases with Proteinuria.

Authors:  Amnuay Sirisopha; Somlak Vanavanan; Anchalee Chittamma; Bunyong Phakdeekitcharoen; Ammarin Thakkinstian; Amornpan Lertrit; Nuankanya Sathirapongsasuti; Chagriya Kitiyakara
Journal:  Int J Nephrol       Date:  2016-07-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.